Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

    0
    191

    VIENNA, March 31, 2023 /PRNewswire/ — Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More

    Contact:
    Uschi Mayer
    External Communications & PR
    CROMA-PHARMA GmbH
    Cromazeile 2, A-2100 Leobendorf, Austria
    M.: +43 676 84 68 68 966
    E: uschi.mayer@croma.at